| abstract |
A medicinal composition for the prevention or treatment of diseases attributable to vascular intimal proliferation, such as restricture after operations for coronary intervention. The medicinal composition for the prevention or treatment of diseases attributable to vascular intimal proliferation, such as restricture after operations for coronary intervention, contains as an active ingredient any of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)~propionic acid, which is represented by the following formula (general name: mitiglinide), pharmacologically acceptable salts of the acid, and hydrates of these. |